Thrombopoietin Receptor MPL in Hematopoiesis and Myeloproliferative Neoplasms: Physiological Roles and Pathogenic Mechanisms.

Key claim: The thrombopoietin receptor MPL plays central physiological roles in hematopoiesis and, when mutated or dysregulated, drives pathogenic mechanisms underlying myeloproliferative neoplasms.

Abstract

No abstract available.

Why this matters

Pending synthesis.

Source

Link